“Now that I have it, I Don’t Know How I’d Live Without It”: A Skeptical Parkinson’s Neurologist on Two Months with Dannce
“Now that I have it, I Don’t Know How I’d Live Without It”: A Skeptical Parkinson’s Neurologist on Two Months with Dannce
“Now that I have it, I Don’t Know How I’d Live Without It”: A Skeptical Parkinson’s Neurologist on Two Months with Dannce
By Richard Trosch, MD, Movement Disorder Specialist and Head of Clinical at Dannce.ai

A Clinician’s Perspective
As a neurologist who has spent 35 years managing Parkinson’s disease, I’m naturally skeptical of new technology. Many tools promise to change practice and end up as one more login to remember. After only two months leveraging Dannce in my clinic, it has already become part of how I practice, including in ways I didn’t expect.
About Dannce.ai
Dannce.ai is building a clinical intelligence platform to make expert neurological care accessible from anywhere. Built on a decade of movement-science research at Harvard and Duke, our technology analyzes smartphone videos recorded at home to help clinicians assess patients, quantify response to treatment, and create a home-to-clinic care loop for the first time. If you’re living with Parkinson’s or caring for someone who is, download the Dannce app, try it out, and share it with your neurologist.
A Clinician’s Perspective
As a neurologist who has spent 35 years managing Parkinson’s disease, I’m naturally skeptical of new technology. Many tools promise to change practice and end up as one more login to remember. After only two months leveraging Dannce in my clinic, it has already become part of how I practice, including in ways I didn’t expect.
About Dannce.ai
Dannce.ai is building a clinical intelligence platform to make expert neurological care accessible from anywhere. Built on a decade of movement-science research at Harvard and Duke, our technology analyzes smartphone videos recorded at home to help clinicians assess patients, quantify response to treatment, and create a home-to-clinic care loop for the first time. If you’re living with Parkinson’s or caring for someone who is, download the Dannce app, try it out, and share it with your neurologist.
A Clinician’s Perspective
As a neurologist who has spent 35 years managing Parkinson’s disease, I’m naturally skeptical of new technology. Many tools promise to change practice and end up as one more login to remember. After only two months leveraging Dannce in my clinic, it has already become part of how I practice, including in ways I didn’t expect.
About Dannce.ai
Dannce.ai is building a clinical intelligence platform to make expert neurological care accessible from anywhere. Built on a decade of movement-science research at Harvard and Duke, our technology analyzes smartphone videos recorded at home to help clinicians assess patients, quantify response to treatment, and create a home-to-clinic care loop for the first time. If you’re living with Parkinson’s or caring for someone who is, download the Dannce app, try it out, and share it with your neurologist.
What I Expected Versus What I Found
When I started, I assumed I would mainly use Dannce to track disease progression between scheduled visits, and that remains its long-term promise. What surprised me is how valuable it already is during periods of transition, when a patient’s treatment is changing and the risk of getting the dose wrong is highest. These include:
Deep brain stimulation (DBS) programming and post-operative adjustment
Conversion from immediate-release to extended-release carbidopa-levodopa
Transition to a levodopa infusion pump
Dose reduction because of adverse effects
What I Expected Versus What I Found
When I started, I assumed I would mainly use Dannce to track disease progression between scheduled visits, and that remains its long-term promise. What surprised me is how valuable it already is during periods of transition, when a patient’s treatment is changing and the risk of getting the dose wrong is highest. These include:
Deep brain stimulation (DBS) programming and post-operative adjustment
Conversion from immediate-release to extended-release carbidopa-levodopa
Transition to a levodopa infusion pump
Dose reduction because of adverse effects
What I Expected Versus What I Found
When I started, I assumed I would mainly use Dannce to track disease progression between scheduled visits, and that remains its long-term promise. What surprised me is how valuable it already is during periods of transition, when a patient’s treatment is changing and the risk of getting the dose wrong is highest. These include:
Deep brain stimulation (DBS) programming and post-operative adjustment
Conversion from immediate-release to extended-release carbidopa-levodopa
Transition to a levodopa infusion pump
Dose reduction because of adverse effects
A Case That Showed Me the Value
I recently saw a new patient who was clearly overmedicated. Her exam showed severe, persistent dyskinesias. We started a slow taper, lowering her levodopa dose in small steps each week. I asked her to submit a short video each week, which let me watch her response to every reduction. Because of that, we reached a safe dose without overshooting into motor deterioration. Without the videos I would have been tapering largely blind. The alternative was an in-person visit after every reduction, which would have slowed the path to her final dose and put the burden of repeated trips to the clinic on her.
A Case That Showed Me the Value
I recently saw a new patient who was clearly overmedicated. Her exam showed severe, persistent dyskinesias. We started a slow taper, lowering her levodopa dose in small steps each week. I asked her to submit a short video each week, which let me watch her response to every reduction. Because of that, we reached a safe dose without overshooting into motor deterioration. Without the videos I would have been tapering largely blind. The alternative was an in-person visit after every reduction, which would have slowed the path to her final dose and put the burden of repeated trips to the clinic on her.
A Case That Showed Me the Value
I recently saw a new patient who was clearly overmedicated. Her exam showed severe, persistent dyskinesias. We started a slow taper, lowering her levodopa dose in small steps each week. I asked her to submit a short video each week, which let me watch her response to every reduction. Because of that, we reached a safe dose without overshooting into motor deterioration. Without the videos I would have been tapering largely blind. The alternative was an in-person visit after every reduction, which would have slowed the path to her final dose and put the burden of repeated trips to the clinic on her.
Seeing What Patients Cannot Describe
The same benefit applies after DBS. Patients having side effects often can’t tell tremor from dyskinesia, and those two problems call for opposite fixes. A short video settles the question right away and lets me make the right adjustment quickly.
Medication conversions raise a similar problem. When a patient moves from immediate-release carbidopa-levodopa to an extended-release formulation or an infusion, we calculate an estimated equivalent dose. Experience has taught me that these calculations are educated guesses at best, and most patients need some adjustment up or down. Patients often struggle to describe their symptoms precisely, and a phone call rarely tells me whether they are over- or under-dosed. A video does.
The same is true of the five to ten messages I get on any given day from patients saying something isn’t right: they don’t feel well, or they think they’re having a side effect. Instead of guessing from a vague description, I can ask for a quick video, see the problem for myself, and respond with a specific fix, often the same day.

Rebekah Griesenauer, Head of Product at Dannce.ai, records a patient’s finger-tapping assessment using the Dannce app
Seeing What Patients Cannot Describe
The same benefit applies after DBS. Patients having side effects often can’t tell tremor from dyskinesia, and those two problems call for opposite fixes. A short video settles the question right away and lets me make the right adjustment quickly.
Medication conversions raise a similar problem. When a patient moves from immediate-release carbidopa-levodopa to an extended-release formulation or an infusion, we calculate an estimated equivalent dose. Experience has taught me that these calculations are educated guesses at best, and most patients need some adjustment up or down. Patients often struggle to describe their symptoms precisely, and a phone call rarely tells me whether they are over- or under-dosed. A video does.
The same is true of the five to ten messages I get on any given day from patients saying something isn’t right: they don’t feel well, or they think they’re having a side effect. Instead of guessing from a vague description, I can ask for a quick video, see the problem for myself, and respond with a specific fix, often the same day.

Rebekah Griesenauer, Head of Product at Dannce.ai, records a patient’s finger-tapping assessment using the Dannce app
Seeing What Patients Cannot Describe
The same benefit applies after DBS. Patients having side effects often can’t tell tremor from dyskinesia, and those two problems call for opposite fixes. A short video settles the question right away and lets me make the right adjustment quickly.
Medication conversions raise a similar problem. When a patient moves from immediate-release carbidopa-levodopa to an extended-release formulation or an infusion, we calculate an estimated equivalent dose. Experience has taught me that these calculations are educated guesses at best, and most patients need some adjustment up or down. Patients often struggle to describe their symptoms precisely, and a phone call rarely tells me whether they are over- or under-dosed. A video does.
The same is true of the five to ten messages I get on any given day from patients saying something isn’t right: they don’t feel well, or they think they’re having a side effect. Instead of guessing from a vague description, I can ask for a quick video, see the problem for myself, and respond with a specific fix, often the same day.

Rebekah Griesenauer, Head of Product at Dannce.ai, records a patient’s finger-tapping assessment using the Dannce app
Why Telemedicine Isn’t the Answer for My Clinic
In theory, telemedicine could do some of this. In practice, my clinic doesn’t have the staff or capacity. We are fully booked with in-office visits and can set aside only half a day per month for telemedicine. Dannce works asynchronously: patients record when it suits them, and I review when I have time, without adding appointments to an already full schedule.
Why Telemedicine Isn’t the Answer for My Clinic
In theory, telemedicine could do some of this. In practice, my clinic doesn’t have the staff or capacity. We are fully booked with in-office visits and can set aside only half a day per month for telemedicine. Dannce works asynchronously: patients record when it suits them, and I review when I have time, without adding appointments to an already full schedule.
Why Telemedicine Isn’t the Answer for My Clinic
In theory, telemedicine could do some of this. In practice, my clinic doesn’t have the staff or capacity. We are fully booked with in-office visits and can set aside only half a day per month for telemedicine. Dannce works asynchronously: patients record when it suits them, and I review when I have time, without adding appointments to an already full schedule.
Looking Ahead
Two months in, I believe the direct visual access Dannce gives clinicians will become an essential part of managing Parkinson’s disease. In my experience so far, it improves the quality of care, widens access to care, and speeds up the delivery of that care. For a skeptical neurologist, that is a high bar, and this tool has cleared it.
Looking Ahead
Two months in, I believe the direct visual access Dannce gives clinicians will become an essential part of managing Parkinson’s disease. In my experience so far, it improves the quality of care, widens access to care, and speeds up the delivery of that care. For a skeptical neurologist, that is a high bar, and this tool has cleared it.
Looking Ahead
Two months in, I believe the direct visual access Dannce gives clinicians will become an essential part of managing Parkinson’s disease. In my experience so far, it improves the quality of care, widens access to care, and speeds up the delivery of that care. For a skeptical neurologist, that is a high bar, and this tool has cleared it.
From the Dannce.ai Team: AI That Measures What the Video Shows
Today, as Dr. Trosch describes, the clinician’s eye does the work. We are now adding AI that analyzes each video: novel computer vision methods that track a patient in 3D space and turn that movement into objective, easy-to-read measurements.
That means a clinician no longer has to rely on memory alone when comparing this month’s video with last month’s. Dannce produces measurement of movement performance, tracked from session to session beside the video itself. The clinician still makes every clinical judgment. The measurement gives that evaluation a quantitative reference.
From the Dannce.ai Team: AI That Measures What the Video Shows
Today, as Dr. Trosch describes, the clinician’s eye does the work. We are now adding AI that analyzes each video: novel computer vision methods that track a patient in 3D space and turn that movement into objective, easy-to-read measurements.
That means a clinician no longer has to rely on memory alone when comparing this month’s video with last month’s. Dannce produces measurement of movement performance, tracked from session to session beside the video itself. The clinician still makes every clinical judgment. The measurement gives that evaluation a quantitative reference.
From the Dannce.ai Team: AI That Measures What the Video Shows
Today, as Dr. Trosch describes, the clinician’s eye does the work. We are now adding AI that analyzes each video: novel computer vision methods that track a patient in 3D space and turn that movement into objective, easy-to-read measurements.
That means a clinician no longer has to rely on memory alone when comparing this month’s video with last month’s. Dannce produces measurement of movement performance, tracked from session to session beside the video itself. The clinician still makes every clinical judgment. The measurement gives that evaluation a quantitative reference.
Pilot Dannce
If you treat Parkinson’s or other movement disorders, start where Dr. Trosch did: email rob@dannce.ai to request a demo.
If you’re living with Parkinson’s or caring for someone who is, download the Dannce app, try it out, and share it with your neurologist.
Know someone living with Parkinson’s? Share this article and the app with them.
Download the app: Dannce on the App Store
Pilot Dannce
If you treat Parkinson’s or other movement disorders, start where Dr. Trosch did: email rob@dannce.ai to request a demo.
If you’re living with Parkinson’s or caring for someone who is, download the Dannce app, try it out, and share it with your neurologist.
Know someone living with Parkinson’s? Share this article and the app with them.
Download the app: Dannce on the App Store
Pilot Dannce
If you treat Parkinson’s or other movement disorders, start where Dr. Trosch did: email rob@dannce.ai to request a demo.
If you’re living with Parkinson’s or caring for someone who is, download the Dannce app, try it out, and share it with your neurologist.
Know someone living with Parkinson’s? Share this article and the app with them.
Download the app: Dannce on the App Store



Ready to embrace
technology to better manage
your patients?
Book a live demo or find a participating clinic using Dannce.
Turn phone video into clinical-grade motor data



Ready to embrace
technology to better manage
your patients?
Book a live demo or find a participating clinic using Dannce.

